Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$4.76 - $11.25 $147,560 - $348,750
-31,000 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$2.43 - $5.42 $75,330 - $168,020
31,000 New
31,000 $150,000
Q2 2018

Jul 26, 2018

SELL
$4.43 - $5.14 $106,320 - $123,359
-24,000 Closed
0 $0
Q1 2018

Apr 25, 2018

SELL
$4.65 - $5.9 $6,975 - $8,850
-1,500 Reduced 5.88%
24,000 $125,000
Q3 2017

Oct 18, 2017

BUY
$4.35 - $5.25 $110,924 - $133,875
25,500
25,500 $134,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.